Background, development and properties of progestagens, with special reference to medroxyprogesterone acetate (MPA).
D000818:Animals; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D004714:Endometrial Hyperplasia / Q000188:drug therapy; D004717:Endometrium / Q000187:drug effects; D004971:Estrus; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000494:pharmacology*; D008598:Menstruation; D011247:Pregnancy; D011374:Progesterone / Q000502:physiology; D045167:Progesterone Congeners / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology*; D011817:Rabbits
D003280:Contraceptives, Oral, Synthetic; D045167:Progesterone Congeners; D011372:Progestins; D011374:Progesterone; D008525:Medroxyprogesterone